Samuel Backenroth

Insider Reports History

Entity
Individual
Location
489 5 Th Ave., 28 Th Floor, New York, NY
Signature
/s/ Samuel Backenroth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Backenroth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vascular Biogenics Ltd. Chief Financial Officer Ordinary Shares 525K Mar 31, 2023 Direct
Vascular Biogenics Ltd. Chief Financial Officer Restricted Stock Units 175K Mar 31, 2023 Direct

Insider Reports Filed by Samuel Backenroth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VBLT Vascular Biogenics Ltd. Mar 31, 2023 2 $0 4 Apr 18, 2023 Chief Financial Officer
VBLT Vascular Biogenics Ltd. Jan 1, 2023 0 $0 3 Jan 3, 2023 Chief Financial Officer